Chronic intestinal inflammation: Inflammatory bowel disease and colitis-associated colon cancer

Frontiers in Immunology

Volumn 3, Issue MAY, 2012, Pages

  Rubin, Deborah C ^a   Shaker, Anisa ^a   Levin, Marc S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic intestinal inflammation; Colitis associated colon cancer; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

EID: 84867103263     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00107     Document Type: Review

References (107)

1. Abraham,C.,and Cho, J. H. (2009). Inflammatory bowel disease. N. Engl. J. Med. 361,2066-2078
2. Anderson, C. A., Massey, D. C., Barrett, J. C., Prescott, N. J., Tremelling, M., Fisher, S. A., Gwilliam, R., Jacob, J., Nimmo, E. R., Drummond, H., Lees, C. W., Onnie, C. M., Hanson, C., Blaszczyk, K., Ravindrarajah, R.,Hunt, S., Varma, D., Hammond, N., Lewis, G., Attlesey, H., Watkins, N., Ouwehand, W., Strachan, D., McArdle, W., Lewis, C. M.; Well-come Trust Case Control Consor-tium, Lobo, A., Sanderson, J., Jewell, D. P., Deloukas, P., Mansfield, J. C., Mathew, C. G., Satsangi, J., and Parkes, M. (2009). Investigation of Crohn's disease risk loci in ulcerative colitisfurtherdefinestheirmolecular relationship. Gastroenterology 136, 523-529.e3.
3. Aust, D. E., Terdiman, J. P., Wil-lenbucher, R. F., Chang, C. G., Molinaro-Clark, A., Baretton, G. B., Loehrs, U., and Waldman, F. M. (2002). The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 94, 1421-1427.
4. Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., and Gordon, J. I. (2005). Host-bacterial mutualism in the human intestine. Science 307, 1915-1920.
5. Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., Silverberg, M. S., Taylor, K. D., Barmada, M. M., Bit-ton,A.,Dassopoulos,T.,Datta,L. W., Green, T., Griffiths, A. M., Kistner, E. O., Murtha, M. T., Regueiro, M. D., Rotter, J. I., Schumm, L. P., Stein-hart,A. H.,Targan,S. R.,Xavier,R. J.; NIDDK IBD Genetics Consortium, Libioulle,C.,Sandor,C.,Lathrop,M., Belaiche, J., Dewit, O., Gut, I., Heath, S., Laukens, D., Mni, M., Rutgeerts, P., Van Gossum, A., Zelenika, D., Franchimont, D., Hugot, J. P., deVos, M., Vermeire, S., Louis, E.; Belgian-French IBD Consortium; Wellcome TrustCaseControlConsortium,Car-don, L. R., Anderson, C. A., Drum-mond, H., Nimmo, E., Ahmad, T., Prescott, N. J., Onnie, C. M., Fisher, S. A., Marchini, J., Ghori, J., Bump-stead, S., Gwilliam, R., Tremelling, M., Deloukas, P., Mansfield, J., Jew-ell, D., Satsangi, J., Mathew, C. G., Parkes,M.,Georges,M.,andDaly,M. J. (2008). Genome-wide association defines more than 30 distinct suscep-tibility loci for Crohn's disease. Nat. Genet. 40,955-962.
6. Becker, C., M. Fantini, C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., Ito, H., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Galle, P. R., Blessing, M., Rose-John, S., and Neurath, M. F. (2004). TGF-beta suppresses tumor progres-sion in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21, 491-501.
7. Bernstein, C. N., Blanchard, J. F., Kliewer, E., and Wajda, A. (2001). Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91, 854-862.
8. Brentnall, T. A., Crispin, D. A., Rabi-novitch, P. S., Haggitt, R. C., Rubin, C. E., Stevens, A. C., and Burmer, G. C. (1994). Mutations in the p53 gene: an early marker of neoplastic progression in ulcer-ative colitis. Gastroenterology 107, 369-378.
9. Cadwell, K., Liu, J. Y., Brown, S. L., Miyoshi, H., Loh, J., Lennerz, J. K., Kishi, C., Kc, W., Carrero, J. A., Hunt, S., Stone, C. D., Brunt, E. M., Xavier, R. J., Sleckman, B. P., Li, E., Mizushima, N., Stappenbeck, T. S., and Virgin, H. W. IV. (2008). A key roleforautophagyandtheautophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456, 259-263.
10. Cadwell, K., Patel, K. K., Maloney, N. S., Liu, T. C., Ng, A. C., Storer, C. E., Head, R. D., Xavier, R., Stappenbeck, T. S., and Virgin, H. W. (2010). Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145.
11. Calkins, B. M. (1989). A meta-analysis of the role of smoking in inflamma-tory bowel disease. Dig. Dis. Sci. 34, 1841-1854.
12. Canavan, C., Abrams, K. R., and Mayberry, J. (2006). Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's dis-ease. Aliment. Pharmacol. Ther. 23, 1097-1104.
13. Colotta, F., Allavena, P., Sica, A., Garlanda, C., and Mantovani, A. (2009). Cancer-related inflamma-tion, the seventh hallmark of cancer: links to genetic instability. Carcino-genesis 30,1073-1081.
14. Coussens, L. M., and Werb, Z. (2002). Inflammation and cancer. Nature 420,860-867.
15. Danese, S., and Mantovani, A. (2010). Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflam-mation and cancer. Oncogene 29, 3313-3323.
16. Duerr, R. H. (2002). The genetics of inflammatory bowel disease. Gas-troenterol. Clin. NorthAm. 31,63-76.
17. Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abra-ham, C., Regueiro, M., Griffiths, A., Dassopoulos, T., Bitton, A., Yang, H., Targan,S.,Datta,L.W.,Kistner,E.O., Schumm, L. P., Lee, A. T., Gregersen, P. K., Barmada, M. M., Rotter, J. I., Nicolae, D. L., and Cho, J. H. (2006). A genome-wide association study identifies IL23R as an inflam-matory bowel disease gene. Science 314,1461-1463.
18. Dupaul-Chicoine, J., Veretssian, G., Doiron, K., Bergstrom, K. S., McIn-tire, C. R., LeBlanc, P. M., Meunier, C., Turbide, C., Gros, P., Beau-chemin, N., Vallance, B. A., and Saleh, M. (2010). Control of intesti-nal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatorycaspases.Immunity 32, 367-378.
19. Eaden, J. A., Abrams, K. R., and May-berry, J. F. (2001). The risk of col-orectal cancer in ulcerative colitis: a meta-analysis. Gut 48,526-535.
20. Eckburg, P. B., and Relman, D. A. (2007). The role of microbes in Crohn's disease. Clin. Infect. Dis. 44, 256-262.
21. Economou, M., Trikalinos, T. A., Loizou,K.T.,Tsianos,E.V.,andIoan-nidis, J. P. (2004). Differential effects of NOD2 variants on Crohn's dis-ease risk and phenotype in diverse populations: a metaanalysis. Am. J. Gastroenterol. 99,2393-2404.
22. Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia,J.,Thaiss,C.A.,Booth, C. J., Peaper, D. R., Bertin, J., Eisen-barth, S. C., Gordon, J. I., and Flavell, R. A. (2011). NLRP6 inflam-masome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757.
23. Feagins, L. A., Souza, R. F., and Spechler, S. J. (2009). Carcinogen-esis in IBD: potential targets for the prevention of colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 6, 297-305.
24. Fisher, S. A., Tremelling, M., Anderson, C. A., Gwilliam, R., Bumpstead, S., Prescott,N. J.,Nimmo,E. R.,Massey, D., Berzuini, C., Johnson, C., Barrett, J. C., Cummings, F. R., Drummond, H., Lees, C. W., Onnie, C. M, Han-son, C. E., Blaszczyk, K., Inouye, M., Ewels, P., Ravindrarajah, R., Keniry, A., Hunt, S., Carter, M., Watkins, N., Ouwehand, W., Lewis, C. M., Car-don,L.;WellcomeTrustCaseControl Consortium, Lobo, A., Forbes, A., Sanderson,J.,Jewell,D. P.,Mansfield, J. C., Deloukas, P., Mathew, C. G., Parkes, M., and Satsangi, J. (2008). Genetic determinants of ulcerative colitis include the ECM1 locus and fivelociimplicatedinCrohn'sdisease. Nat. Genet. 40, 710-712.
25. Frank, D. N., Robertson, C. E., Hamm, C. M., Kpadeh, Z., Zhang, T., Chen, H., Zhu, W., Sartor, R. B., Boedeker, E. C., Harpaz, N., Pace, N. R., and Li, E. (2011). Disease pheno-typeandgenotypeareassociatedwith shifts in intestinal-associated micro-biotaininflammatoryboweldiseases. Inflamm. Bowel Dis. 17,179-184.
26. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial com-munityimbalancesinhumaninflam-matory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104,13780-13785.
27. Franke, A., Balschun, T., Karlsen, T. H., Hedderich, J., May, S., Lu, T., Schuldt, D., Nikolaus, S., Rosen-stiel, P., Krawczak, M., and Schreiber, S. (2008a). Replication of signals from recent studies of Crohn's dis-ease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 40, 713-715.
28. Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S., Albrecht, M., Nothnagel, M., Ellinghaus, D., Sina, C., Onnie, C. M., Weersma, R. K., Stokkers, P. C., Wijmenga, C., Gazouli, M., Strachan, D., McAr-dle, W. L., Vermeire, S., Rutgeerts, P., Rosenstiel, P., Krawczak, M.,Vatn, M. H.; IBSEN study group, Mathew, C. G., and Schreiber, S. (2008b). Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40, 1319-1323.
29. Franke, A., McGovern, D. P., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., Anderson, C. A., Bis, J. C., Bumpstead, S., Elling-haus, D., Festen, E. M., Georges, M., Green, T., Haritunians, T., Jostins, L., Latiano, A., Mathew, C. G., Mont-gomery, G. W., Prescott, N. J., Ray-chaudhuri, S., Rotter, J. I., Schumm, P.,Sharma,Y.,Simms,L.A.,Taylor,K. D.,Whiteman,D.,Wijmenga,C.,Bal-dassano,R.N.,Barclay,M.,Bayless,T. M., Brand, S., Büning, C., Cohen, A., Colombel,J.F.,Cottone,M.,Stronati, L.,Denson,T.,DeVos,M.,D'Inca,R., Dubinsky,M.,Edwards,C.,Florin,T., Franchimont, D., Gearry, R., Glas, J., Van Gossum,A., Guthery, S. L., Half-varson, J.,Verspaget, H. W., Hugot, J. P.,Karban,A.,Laukens,D.,Lawrance, I., Lemann, M., Levine, A., Libioulle, C., Louis, E., Mowat, C., Newman, W., Panés, J., Phillips, A., Proctor, D. D., Regueiro, M., Russell, R., Rut-geerts, P., Sanderson, J., Sans, M., Seibold,F.,Steinhart,A. H.,Stokkers, P. C., Torkvist, L., Kullak-Ublick, G., Wilson, D., Walters, T., Targan, S. R., Brant, S. R., Rioux, J. D., D'Amato, M., Weersma, R. K., Kugathasan, S., Griffiths, A. M., Mansfield, J. C., Vermeire, S., Duerr, R. H., Silver-berg, M. S., Satsangi, J., Schreiber, S., Cho, J. H., Annese, V., Hakonar-son, H., Daly, M. J., and Parkes, M. (2010). Genome-wide meta-analysis increases to 71 the number of con-firmed Crohn's disease susceptibility loci. Nat. Genet. 42,1118-1125.
30. Fujii, S., Tominaga, K., Kitajima, K., Takeda, J., Kusaka, T., Fujita, M., Ichikawa, K., Tomita, S., Ohkura, Y., Ono, Y., Imura, J., Chiba, T., and Fujimori, T. (2005). Methyla-tion of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstandingandextensiveulcerative colitis. Gut 54,1287-1292.
31. Fujino,S.,Andoh,A.,Bamba,S.,Ogawa, A., Hata, K.,Araki,Y., Bamba, T., and Fujiyama, Y. (2003). Increased exp-ression of interleukin 17 in inflam-matory bowel disease. Gut 52,65-70.
32. Garrity-Park, M. M., Loftus, E. V. Jr., Sandborn, W. J., Bryant, S. C., and Smyrk, T. C. (2010). Methyla-tionstatusof genesinnon-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Am. J. Gastroenterol. 105,1610-1619.
33. Gill, S. R., Pop, M., Deboy, R. T., Eck-burg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., and Nelson, K. E. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359.
34. Glick, D., Barth, S., and Macleod, K. F. (2010). Autophagy: cellular andmolecularmechanisms.J.Pathol. 221, 3-12.
35. Glocker, E. O., Kotlarz, D., Boztug, K., Gertz, E. M., Schäffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., All-roth, A., Murugan, D., Hätscher, N., Pfeifer, D., Sykora, K. W., Sauer, M., Kreipe, H., Lacher, M., Nustede, R., Woellner, C., Baumann, U., Salzer, U., Koletzko, S., Shah, N., Segal, A. W., Sauerbrey, A., Buderus, S., Snapper, S. B., Grimbacher, B., and Klein,C. (2009).Inflammatorybowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361,2033-2045.
36. Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F., and Veldhuyzen van Zanten, S. J. (2006). Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 44,4136-4141.
37. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. Jon and tumor., Kagnoff, M. F., and Karin, M. (2004). IKKbeta links inflammatiigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296.
38. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G. Y., Vallabhapu-rapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., and Karin, M. (2009). IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15,103-113.
39. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson,M.,Sargeant,L.,Krapcho, K., Wolff, E., Burt, R., Hughes, J. P., Warrington, J., McPherson, J., Was-muth, J., Le Paslier, D., Abderrahim, H., Cohen, D., Leppert, M., and White, R. (1991). Identification and characterization of the familial ade-nomatous polyposis coli gene. Cell 66,589-600.
40. Hampe,J.,Franke,A.,Rosenstiel,P.,Till, A.,Teuber,M.,Huse,K.,Albrecht,M., Mayr,G.,De LaVega,F. M.,Briggs,J., Günther, S., Prescott, N. J., Onnie, C. M., Häsler, R., Sipos, B., Fölsch, U. R., Lengauer, T., Platzer, M., Mathew, C. G., Krawczak, M., and Schreiber, S. (2007).Agenome-wideassociation scanofnonsynonymousSNPsidenti-fies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211.
41. Harries, A. D., Baird, A., and Rhodes, J. (1982). Non-smoking: a feature of ulcerative colitis. Br. Med. J. (Clin. Res. Ed.) 284, 706.
42. Hedl, M., Li, J., Cho, J. H., and Abraham, C. (2007). Chronic stimulation of Nod2 mediates tolerance to bac-terial products. Proc. Natl. Acad. Sci. U.S.A. 104,19440-19445.
43. Huett, A., Goel, G., and Xavier, R. J. (2010). A systems biology view-point on autophagy in health and disease.Curr.Opin.Gastroenterol.26, 302-309.
44. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M., and Thomas, G. (2001). Association of NOD2leucine-richrepeatvariants withsusceptibilitytoCrohn'sdisease. Nature 411,599-603.
45. Hussain, S. P., Amstad, P., Raja, K., Ambs, S., Nagashima, M., Ben-nett, W. P., Shields, P. G., Ham, A. J., Swenberg, J. A., Marrogi, A. J., and Harris, C. C. (2000). Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 60,3333-3337.
46. Issa, J. P., Ahuja, N., Toyota, M., Bron-ner,M.P.,andBrentnall,T.A. (2001). Accelerated age-related CpG island methylationinulcerativecolitis.Cancer Res. 61, 3573-3577.
47. Itzkowitz, S. H., and Yio, X. (2004). Inflammation and cancer IV. Col-orectalcancerininflammatorybowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G7-G17.
48. Kappelman, M. D., Rifas-Shiman, S. L., Kleinman, K., Ollendorf, D., Bous-varos, A., Grand, R. J., and Finkel-stein,J.A. (2007).Theprevalenceand geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin. Gastroenterol. Hepatol. 5,1424-1429.
49. Kaser,A.,Zeissig,S.,andBlumberg,R.S. (2010). Inflammatory bowel disease. Annu. Rev. Immunol. 28,573-621.
50. Kawanishi, S., Hiraku, Y., Pinlaor, S., and Ma, N. (2006). Oxidative and nitrativeDNAdamageinanimalsand patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 387, 365-372.
51. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Müller, W. (1993).Interleukin-10-deficientmice developchronicenterocolitis.Cell 75, 263-274.
52. Kundu, J. K., and Surh, Y. J. (2008). Inflammation:gearingthejourneyto cancer. Mutat. Res. 659,15-30.
53. Kuster, W., Pascoe, L., Purrmann, J., Funk, S., and Majewski, F. (1989). The genetics of Crohn disease: com-plex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am. J. Med. Genet. 32,105-108.
54. Lesage, S., Zouali, H., Cézard, J. P., Colombel, J. F., Belaiche, J., Almer, S., Tysk, C., O'Morain, C., Gassull, M., Binder, V., Finkel, Y., Modigliani, R., Gower-Rousseau, C., Macry, J., Merlin, F., Chamaillard, M., Jan-not, A. S., Thomas, G., Hugot, J. P.; EPWG-IBD Group; EPIMAD Group; and GETAID Group. (2002). CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory boweldisease.Am. J.Hum. Genet. 70, 845-857.
55. Liao, J., Seril, D. N., Lu, G. G., Zhang, M., Toyokuni, S., Yang, A. L., and Yang, G. Y. (2008). Increased susceptibility of chronic ulcerative colitis-induced carcinoma develop-ment in DNA repair enzyme Ogg1 deficient mice. Mol. Carcinog. 47, 638-646.
56. Lidar, M., Langevitz, P., and Shoenfeld, Y. (2009). The role of infection in inflammatory bowel disease: initia-tion,exacerbationandprotection.Isr. Med. Assoc. J. 11,558-563.
57. Loftus, E. V. Jr. (2007). The burden of inflammatory bowel disease in the United States: a moving target? Clin. Gastroenterol. Hepatol. 5,1383-1384.
58. Manichanh, C., Rigottier-Gois, L., Bon-naud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon,P.,Marteau,P.,Roca,J.,and Dore, J. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealedbyametagenomicapproach. Gut 55, 205-211.
59. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
60. Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., Schauer, D. B., Dedon, P. C., Fox, J. G., and Samson, L. D. (2008). DNA damage induced by chronic inflam-mation contributes to colon carcino-genesis in mice. J. Clin. Invest. 118, 2516-2525.
61. Miller, B. C., Zhao, Z., Stephenson, L. M., Cadwell, K., Pua, H. H., Lee, H. K., Mizushima, N. N., Iwasaki, A., He, Y. W., Swat, W., and Virgin, H. W. IV. (2008). The autophagy gene ATG5playsanessentialroleinBlym-phocyte development. Autophagy 4, 309-314.
62. Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., and Tonegawa, S. (1993). Spon-taneous development of inflamma-tory bowel disease in T cell receptor mutant mice. Cell 75,274-282.
63. Nell,S.,Suerbaum,S.,andJosenhans,C. (2010). Theimpactof themicrobiota on the pathogenesis of IBD: lessons from mouse infection models. Nat. Rev. Microbiol. 8, 564-577.
64. Neufert, C., Becker, C., and Neurath, M. F. (2007). An inducible mouse model of colon carcinogene-sis for the analysis of sporadic and inflammation-driventumorprogres-sion. Nat. Protoc. 2,1998-2004.
65. Neurath, M. F., and Finotto, S. (2009). Translating inflammatory bowel dis-ease research into clinical medicine. Immunity 31, 357-361.
66. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nuñez, G., and Cho, J. H. (2001). A frameshift mutation in NOD2 associated with susceptibil-ity to Crohn's disease. Nature 411, 603-606.
67. Orholm, M., Binder, V., Sørensen, T. I., Rasmussen, L. P., and Kyvik, K. O. (2000). Concordance of inflam-matory bowel disease among Dan-ish twins. Results of a nationwide study. Scand. J. Gastroenterol. 35, 1075-1081.
68. Pabst, O., Zweigerdt, R., and Arnold, H. H. (1999). Targeted disruption of thehomeoboxtranscriptionfactor Nkx2-3 in mice results in postna-tal lethality and abnormal develop-ment of small intestine and spleen. Development 126,2215-2225.
69. Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. R., Soars, D., Drummond, H., Lees, C. W.,Khawaja,S.A.,Bagnall,R.,Burke, D. A., Todhunter, C. E., Ahmad, T., Onnie,C. M.,McArdle,W.,Strachan, D., Bethel, G., Bryan, C., Lewis, C. M., Deloukas, P., Forbes, A., Sander-son, J., Jewell, D. P., Satsangi, J., Mansfield,J. C.;Wellcome Trust Case ControlConsortium,Cardon,L.,and Mathew,C.G. (2007).Sequencevari-ants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease suscep-tibility. Nat. Genet. 39, 830-832.
70. Pullan, R. D., Rhodes, J., Ganesh, S., Mani,V.,Morris,J.S.,Williams,G.T., Newcombe, R. G., Russell, M., Fey-erabend, C., Thomas, G., and Sawe, U. (1994). Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 330,811-815.
71. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., Batto, J. M., Hansen, T., Le Paslier, D., Lin-neberg, A., Nielsen, H. B., Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak,S.,Doré,J.,Guarner,F.,Kris-tiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J.; MetaHIT Con-sortium, Bork, P., Ehrlich, S. D., and Wang, J. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
72. Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S., Takashi, S., Baik, G. H., Shibata, W., Diprete, B., Betz, K. S., Friedman, R., Varro, A., Tycko, B., and Wang, T. C. (2011). Bonemarrow-derivedmyofi-broblastscontributetothemesenchy-mal stem cell niche and promote tumor growth. Cancer Cell 19, 257-272.
73. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004). Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
74. Redston, M. S., Papadopoulos, N., Caldas,C.,Kinzler,K.W.,and Kern,S. E. (1995). Common occurrence of APC andK-rasgenemutationsinthespec-trum of colitis-associated neoplasias. Gastroenterology 108,383-392.
75. Reiff, C., and Kelly, D. (2010). Inflam-matory bowel disease, gut bacteria and probiotic therapy. Int. J. Med. Microbiol. 300,25-33.
76. Rosenstiel, P., Sina, C., Franke, A., and Schreiber, S. (2009). Towards a molecular risk map-recent advances on the etiology of inflammatory bowel disease. Semin. Immunol. 21, 334-345.
77. Rubtsov, Y., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R. Jr., Muller, W., and Rudensky, A. Y. (2008). Regu-latory T cell-derived interleukin-10 limits inflammation at environmen-tal interfaces. Immunity 28, 546-558.
78. Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., and Forbes, A. (2004). Severity of inflammation is a risk factor for col-orectal neoplasia in ulcerative colitis. Gastroenterology 126,451-459.
79. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., and Horak, I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75,253-261.
80. Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R. M., Wang, E., Ma, W., Haines, D., O'hUigin, C., Marincola, F. M., and Trinchieri, G. (2010). MyD88-mediated signaling prevents devel-opment of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207,1625-1636.
81. Sandborn,W.J.,Tremaine,W.J.,Offord, K. P., Lawson, G. M., Petersen, B. T., Batts, K. P., Croghan, I. T., Dale, L. C., Schroeder, D. R., and Hurt, R. D. (1997). Transdermal nicotine for mildlytomoderatelyactiveulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 126,364-371.
82. Sellon,R.K.,Tonkonogy,S.,Schultz,M., Dieleman,L.A.,Grenther,W.,Balish, E., Rennick, D. M., and Sartor, R. B. (1998). Resident enteric bacteria are necessary for development of spon-taneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66,5224-5231.
83. Shaker, A., and Rubin, D. C. (2011). Intestinal stem cells and epithelial-mesenchymal interactions in the crypt and stem cell niche. Transl. Res. 156,180-187.
84. Shaker, A., Swietlicki, E. A., Wang, L., Jiang, S., Onal, B., Bala, S., DeSchryver, K., Newberry, R., Levin, M. S., and Rubin, D. C. (2010). Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell nichemyofibroblastsecretion.J.Clin. Invest. 120,2081-2093.
85. Sheikh, S. Z., Hegazi, R. A., Kobayashi, T., Onyiah, J. C., Russo, S. M., Matsuoka, K., Sepulveda, A. R., Li, F., Otterbein, L. E., and Plevy, S. E. (2011). An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J. Immunol. 186,5506-5513.
86. Silverberg, M. S., Cho, J. H., Rioux, J. D., McGovern, D. P., Wu, J., Annese, V., Achkar, J. P., Goyette, P., Scott, R., Xu, W., Barmada, M. M., Klei, L., Daly, M. J., Abraham, C., Bay-less, T. M., Bossa, F., Griffiths, A. M., Ippoliti, A. F., Lahaie, R. G., Latiano, A., Paré, P., Proctor, D. D., Regueiro, M. D., Steinhart, A. H., Targan, S. R., Schumm, L. P., Kistner, E. O., Lee, A. T., Gregersen, P. K., Rotter, J. I., Brant, S. R., Taylor, K. D., Roeder, K., and Duerr, R. H. (2009). Ulcera-tive colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat. Genet. 41, 216-220.
87. Singh, S. B., Davis, A. S., Taylor, G. A., and Deretic,V. (2006).HumanIRGM inducesautophagytoeliminateintra-cellular mycobacteria. Science 313, 1438-1441.
88. Solinas, G., Marchesi, F., Garlanda, C., Mantovani, A., and Allavena, P. (2010). Inflammation-mediated pro-motion of invasion and metastasis. Cancer Metastasis Rev. 29, 243-248.
89. Strober, W., and Fuss, I. J. (2011). Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1756-1767.
90. Strober, W., Fuss, I. J., and Blumberg, R. S. (2002). The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20,495-549.
91. Suzuki, R., Kohno, H., Sugie, S., Nakagama, H., and Tanaka, T. (2006). Straindifferencesinthesusceptibility toazoxymethaneanddextransodium sulfate-induced colon carcinogen-esis in mice. Carcinogenesis 27, 162-169.
92. Tanaka, F., Tominaga, K., Ochi, M., Tanigawa, T., Watanabe, T., Fujiwara, Y., Ohta, K., Oshitani, N., Higuchi, K., and Arakawa, T. (2008). Exoge-nousadministrationofmesenchymal stem cells ameliorates dextran sul-fate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. 83,771-779.
93. Tarmin, L., Yin, J., Harpaz, N., Kozam, M., Noordzij, J., Antonio, L. B., Jiang, H. Y., Chan, O., Cymes, K., and Meltzer, S. J. (1995). Adenoma-tous polyposis coli gene mutations in ulcerative colitis-associated dys-plasias and cancers versus sporadic colon neoplasms. Cancer Res. 55, 2035-2038.
94. Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., Balish, E., and Hammer, R. E. (1994). The germfree state prevents development of gutandjointinflammatorydisease in HLA-B27 transgenic rats. J. Exp. Med. 180,2359-2364.
95. Terzic,J.,Grivennikov,S.,Karin,E.,and Karin, M. (2010). Inflammation and colon cancer. Gastroenterology 138, 2101-2114.e5.
96. Tsuji, S., Uehori, J., Matsumoto, M., Suzuki,Y., Matsuhisa,A., Toyoshima, K., and Seya, T. (2001). Human int-electin is a novel soluble lectin that recognizes galactofuranose in carbo-hydratechainsof bacterialcellwall. J. Biol. Chem. 276,23456-23463.
97. Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., and Gordon, J. I. (2007). The human microbiome project. Nature 449,804-810.
98. Tysk, C., Lindberg, E., Järnerot, G., and Flodérus-Myrhed, B. (1988). Ulcer-ative colitis and Crohn's disease in anunselectedpopulationofmonozy-gotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29,990-996.
99. Ullman, T. A., and Itzkowitz, S. H. (2011). Intestinal inflammation and cancer. Gastroenterology 140, 1807- 1816.
100. Unkart,J. T.,Anderson,L.,Li,E.,Miller, C., Yan, Y., Gu, C. C., Chen, J., Stone, C. D., Hunt, S., and Dietz, D. W. (2008). Risk factors for surgi-calrecurrenceafterileocolicresection of Crohn'sdisease. Dis. ColonRectum 51, 1211-1216.
101. Vermeulen, L., De Sousa, E. M. F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Roder-mond, H., Sprick, M. R., Kemper, K., Richel, D. J., Stassi, G., and Medema, J.P. (2010).Wntactivitydefinescolon cancer stem cells and is regulated by themicroenvironment.Nat.CellBiol. 12, 468-476.
102. Watanabe, T., Kitani, A., Murray, P. J., and Strober, W. (2004). NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.Nat.Immunol.5,800-808.
103. Westbrook, A. M., Szakmary, A., and Schiestl, R. H. (2010). Mechanisms of intestinalinflammationanddevel-opmentof associatedcancers:lessons learned from mouse models. Mutat. Res. 705, 40-59.
104. Worthley,D.L.,Giraud,A.S.,andWang, T. C. (2010). Stromal fibroblasts in digestive cancer. Cancer Microenvi-ron. 3,117-125.
105. Wrackmeyer, U., Hansen, G. H., Seya, T., and Danielsen, E. M. (2006). Int-electin: a novel lipid raft-associated protein in the enterocyte brush bor-der. Biochemistry 45,9188-9197.
106. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKen-zie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., Murphy, E., Sathe, M., Cua, D. J., Kastelein, R. A., and Rennick, D. (2006). IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116,1310-1316.
107. Zhang, R., Ma, A., Urbanski, S. J., and McCafferty, D. M. (2007). Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma. Carcino-genesis 28, 1122-1130.